14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $6.22 $6.22 Friday, 27th Jan 2023 LJPC stock ended at $6.22. During the day the stock fluctuated 0% from a day low at $6.22 to a day high of $6.22.
90 days $6.22 $6.22
52 weeks $3.07 $6.24

Historical La Jolla Pharmaceutical Company prices

Date Open High Low Close Volume
Dec 20, 2022 $6.22 $6.22 $6.22 $6.22 0
Dec 19, 2022 $6.22 $6.22 $6.22 $6.22 0
Dec 16, 2022 $6.22 $6.22 $6.22 $6.22 0
Dec 15, 2022 $6.22 $6.22 $6.22 $6.22 0
Dec 14, 2022 $6.22 $6.22 $6.22 $6.22 0
Dec 13, 2022 $6.22 $6.22 $6.22 $6.22 0
Dec 12, 2022 $6.22 $6.22 $6.22 $6.22 0
Dec 09, 2022 $6.22 $6.22 $6.22 $6.22 0
Dec 08, 2022 $6.22 $6.22 $6.22 $6.22 0
Dec 07, 2022 $6.22 $6.22 $6.22 $6.22 0
Dec 06, 2022 $6.22 $6.22 $6.22 $6.22 0
Dec 05, 2022 $6.22 $6.22 $6.22 $6.22 0
Dec 02, 2022 $6.22 $6.22 $6.22 $6.22 0
Dec 01, 2022 $6.22 $6.22 $6.22 $6.22 0
Nov 30, 2022 $6.22 $6.22 $6.22 $6.22 0
Nov 29, 2022 $6.22 $6.22 $6.22 $6.22 0
Nov 28, 2022 $6.22 $6.22 $6.22 $6.22 0
Nov 25, 2022 $6.22 $6.22 $6.22 $6.22 0
Nov 23, 2022 $6.22 $6.22 $6.22 $6.22 0
Nov 22, 2022 $6.22 $6.22 $6.22 $6.22 0
Nov 21, 2022 $6.22 $6.22 $6.22 $6.22 0
Nov 18, 2022 $6.22 $6.22 $6.22 $6.22 0
Nov 17, 2022 $6.22 $6.22 $6.22 $6.22 0
Nov 16, 2022 $6.22 $6.22 $6.22 $6.22 0
Nov 15, 2022 $6.22 $6.22 $6.22 $6.22 0
Click to get the best stock tips daily for free!

About La Jolla Pharmaceutical Company

La Jolla Pharmaceutical Company La Jolla Pharmaceutical Company engages in the development and commercialization of therapies that improve outcomes in patients suffering from life-threatening diseases. The company offers GIAPREZA, a vasoconstrictor indicated to increase blood pressure in adults with septic or other distributive shock; and XERAVA, a tetracycline class antibacterial indicated for the treatment of complicated intra-abdominal infections in patients 18 years of age ... LJPC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT